Romain Zufferey got his MD degree from the Geneva University Medical School in 1988 and his PhD degree in molecular biology from the Zurich University in 1996. His strong interests in gene therapy lead him to the Salk Institute in San Diego where he contributed significantly to the development of safe, clinically acceptable lentiviral vectors (1996 to 1998). After 5 years of research experience both in the academic and the industrial environment he joined the Swiss Federal Institute for Technology in 2003. In Lausanne, Dr. Zufferey has focused his research on gene delivery related to Parkinson’s disease. Among other academic distinctions, Dr. Zufferey was awarded the young investigator award of the American Society for Gene Therapy in 1998.